Novo's M&A leader leaves for Forbion; Perrigo CEO's 'personal conduct' issues led to resignation

June 12, 2026 07:00 AM EDT Peer Review Novo's M&A leader leaves for For­bion; Per­ri­go CEO's 'per­son­al con­duc­t' is­sues led to res­ig­na­tion Alex Hoffman Copy Chief and News Editor Kyle LaHucik Biotech Correspondent Max Bayer Senior Reporter For­bion’s port­fo­lio com­pa­nies have been no stranger to M&A deals in re­cent years. But the Dutch in­vest­ment firm now … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER